04:07 PM EDT, 07/22/2024 (MT Newswires) -- Andrew Guggenhime, President and CFO, on July 18, 2024, sold 8,000 shares in Vaxcyte ( PCVX ) for $649,325. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 96,720 shares of the company, with 96,720 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000164909424000038/xslF345X03/wk-form4_1721678591.xml